Research output per year
Research output per year
Fingerprint
Dive into the research topics where Katrien Glorieus is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Phase II Trial Assessing the Repeatability and Tumor Uptake of [68Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma
Gondry, O., Caveliers, V., Xavier, C., Vanhoeij, M., Verfaillie, G., Fontaine, C., Glorieus, K., De Grève, J., Joris, S., Luyten, I., Zwaenepoel, K., Vandenbroucke, F., Waelput, W., Thyparambil, S., Vaneycken, I., Cousaert, J., Bourgeois, S., Devoogdt, N., Goethals, L., Everaert, H. & 4 others, , 1 Feb 2024, In: Journal of Nuclear Medicine. 65, 2, p. 178-184 7 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Citations (Scopus)41 Downloads (Pure) -
A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients.
Gondry, O., Xavier, C., Heemskerk, J., Raes, L. A. J., Debacker, J., De Geeter, F., Fontaine, C., Vanhoeij, M., Aspeslagh, S., Joris, S., De Grève, J., Verfaillie, G., Luyten, I., De Mey, L., Vandenbroucke, F., Waelput, W., Glorieus, K., Bourgeois, S., Cousaert, J., Vaneycken, I. & 5 others, , 2023.Research output: Unpublished contribution to conference › Unpublished abstract
-
Assessment of repeatability and uptake quantification of (68)GaNOTA-anti-HER2 sdAb PET/CT in patients with locally advanced or metastatic breast cancer
Gondry, O., Xavier, C., Waelput, W., Al Dabssi, O., Vanhoeij, M., Aspeslagh, S., Joris, S., Fontaine, C., Verfaillie, G., De Greve, J., Glorieus, K., Luyten, I., Vandenbroucke, F., Bourgeois, S., Thyparambil, S., Devoogdt, N., Vaneycken, I., Cousaert, J., Caveliers, V., Everaert, H. & 3 others, , 15 Feb 2022, In: Cancer Research. 82, 4, p. P3-02-05Research output: Contribution to journal › Meeting abstract (Journal)
Open Access -
Repeatability of 68GaNOTA-anti-HER2 sdAb in 20 breast cancer patients.
Gondry, O., Xavier, C., De Geeter, F., Al dabssi, O., Glorieus, K., Aspeslagh, S., Joris, S., Fontaine, C., Verfaillie, G., De Grève, J., Vanhoeij, M., Luyten, I., Heemskerk, J., Bourgeois, S., Raes, L. A. J., Devoogdt, N., Vaneycken, I., Cousaert, J., Caveliers, V., Everaert, H. & 2 others, , Mar 2022.Research output: Unpublished contribution to conference › Unpublished abstract
-
Intravasculaire leiomyomatose: een moeilijke maar belangrijke diagnose.
Glorieus, K., Cosyns, S., Dehou, M. F. & Simon, P., 1 May 2020, In: Gunaïkeia (Nederlandse ed.). 25, 5, p. 27-29 2 p.Research output: Contribution to journal › Article › peer-review
-
42nd Congress of the European Society of Surgical Oncology
Daniel Jacobs-Tulleneers-Thevissen (Chair), Ine Luyten (Participant) & Katrien Glorieus (Participant)
25 Oct 2023 → 27 Oct 2023Activity: Participating in or organising an event › Participation in conference
-
Borstkanker en preventie
Katrien Glorieus (Speaker)
15 Dec 2022Activity: Talk or presentation › Talk or presentation at a conference
-
(R)evoluties in borstkankerbehandeling
Laurens De Vleminck (Participant), Karl Waked (Participant), Mary-Louise Bonduelle (Participant), Ellen Van Asbroeck (Participant), Randy De Baerdemaeker (Participant), Kim Van Berkel (Participant), Fien Janssens (Participant), Tom Danau (Participant), Axelle Stockmans (Participant), Thomas Van den Eynde (Participant), Geertje Miedema (Participant), Nele Platteaux (Participant), Constance Yvonne Carels (Participant), Guy Verfaillie (Participant), Katrien Glorieus (Participant), Gaëlle Wilmet (Participant), Dirk Smets (Participant), Alexandra Sermeus (Participant), Alexander Haitham Turaihi (Participant) & Mark De Ridder (Participant)
9 Jun 2022Activity: Participating in or organising an event › Participation in conference